Novel Computational Approaches for Molecular Target Discovery in Colorectal Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Methods and Technologies Development".
Deadline for manuscript submissions: 30 December 2024 | Viewed by 123
Special Issue Editor
Interests: mutations; tumor heterogeneity; genetics; bioinformatics; clonal evolution; target therapy; secondary resistance; tumor burden; next-generation sequencing; liquid biopsy; colorectal cancers; clinical trial; immunotherapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Colorectal cancer (CRC) remains a global health challenge, ranking as the third-most prevalent and lethal cancer worldwide. While progress in CRC incidence and mortality reduction has been made through screening programs, lifestyle interventions, and advancements in diagnostic and therapeutic modalities, there is still a pressing need for novel and more effective treatment strategies. Technology plays a pivotal role in this context, enabling physicians to enhance diagnostic accuracy, patient monitoring, and the development of individualized, less invasive therapies.
Moreover, technological advancements have empowered the accumulation of vast genetic datasets, which can be harnessed using innovative bioinformatic approaches to identify new therapeutic targets and refine patient stratification for personalized care. We dedicate this Special Issue to the exploration of novel genetic targets through advanced bioinformatic methods, aiming to revolutionize patient stratification and potentially harboring clinical translation.
Original articles are welcome as well as methodology reports related to recently published groundbreaking publications addressing the specific field of this Special Issue.
Dr. Giovanni Crisafulli
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- colorectal cancer
- genetics
- bioinformatics
- therapeutic targets
- cancer evolution
- personalized medicine
- patient stratification
- technological advancements
- precision oncology
- big data
- computational approach
